Family ties: Relationship between human and zebrafish genomes

Completion of the zebrafish reference genome yields strong comparisons with the human genome

2013-04-18

(Press-News.org) Researchers demonstrate today that 70 per cent of protein-coding human genes are related to genes found in the zebrafish and that 84 per cent of genes known to be associated with human disease have a zebrafish counterpart. Their study highlights the importance of zebrafish as a model organism for human disease research.

The team developed a high-quality annotated zebrafish genome sequence to compare with the human reference genome. Only two other large genomes have been sequenced to this high standard: the human genome and the mouse genome. The completed zebrafish genome will be an essential resource that drives the study of gene function and disease in people.

At first glance, Zebrafish may seem to be a strange comparator to humans, but like us they are vertebrates and we share a common ancestor. They are remarkably biologically similar to people and share the majority of the same genes as humans, making them an important model for understanding how genes work in health and disease.

"Our aim with this project, like with all biomedical research, is to improve human health," says Dr Derek Stemple, senior author from the Wellcome Trust Sanger Institute. "This genome will allow researchers to understand how our genes work and how genetic variants can cause disease in ways that cannot be easily studied in humans or other organisms."

Zebrafish research has already led to biological advances in cancer and heart disease research, and is advancing our understanding of muscle and organ development. Zebrafish have been used to verify the causal gene in muscular dystrophy disorders and also to understand the evolution and formation of melanomas or skin cancers.

"The vast majority of human genes have counterparts in the zebrafish, especially genes related to human disease," says Professor Jane Rogers, senior author formerly at The Genome Analysis Centre. "This high quality genome is testament to the many scientists who worked on this project and will spur biological research for years to come.

"By modeling these human disease genes in zebrafish, we hope that resources worldwide will produce important biological information regarding the function of these genes and possibly find new targets for drug development."

The zebrafish genome has some unique features, not seen in other vertebrates. They have the highest repeat content in their genome sequences so far reported in any vertebrate species: almost twice as much as seen in their closest relative, the common carp. Also unique to the zebrafish, the team identified chromosomal regions that influence sex determination.

The zebrafish genome contains few pseudogenes - genes thought to have lost their function through evolution - compared to the human genome. The team identified 154 pseudogenes in the zebrafish genome, a fraction of the 13,000 or so pseudogenes found in the human genome.

"To realize the benefits the zebrafish can make to human health, we need to understand the genome in its entirety – both the similarities to the human genome and the differences," says Professor Christiane Nüsslein-Volhard, author and Nobel laureate from the Max Planck Institute for Developmental Biology. "Armed with the zebrafish genome, we can now better understand how changes to our genomes result in disease."

"This genome will help to uncover the biological processes responsible for common and rare disease and opens up exciting new avenues for disease screening and drug development," adds Dr Stemple.

### Notes to Editors Publication Details Kerstin Howe, Matthew D. Clark, et al (2013) „The Zebrafish Reference Genome Sequence and its Relationship to the Human Genome‟ Advanced online publication in Nature, 17 April DOI: 10.1038/nature12111

Funding A full list of funding can be found on the paper

Participating Centres 1. Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom 2. The Genome Analysis Centre, Norwich Research Park, Norwich, NR4 7UH, United Kingdom 3. Bioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares, 28029 Madrid, Spain 4. Ecole Normale Supérieure, Institut de Biologie de l‟ENS, IBENS, Paris, F-75005 France 5. Inserm, U1024, Paris, F-75005 France 6. CNRS, UMR 8197, Paris, F-75005 France 7. EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom 8. Illumina Cambridge Ltd., Chesterford Research Park, Little Chesterford, Saffron 9. Walden CB10 1XL UK 10. Hubrecht Laboratory, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands 11. Max Planck Institute for Developmental Biology, Spemannstr. 35, 72076 Tübingen, Germany 12. Stem Cell Program and Division of Hematology/Oncology, Children's Hospital and Dana Farber Cancer Institute, 1 Blackfan Cir., Karp 7, Boston, MA 02115, USA 13. Children's Hospital Oakland, 747 52nd St. Oakland, Ca. 94609, USA 14. Institute of Neuroscience, University of Oregon, 1254 University of Oregon, 222 Huestis Hall, Eugene, OR 97403-1254 15. Karlsruhe Institute of Technology (KIT), Campus North, Institute of Toxicology and Gentics (ITG), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany 16. Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA

Selected Websites

TGAC is a research institute focused on the development of genomics and computational biology. TGAC is based within the Norwich Research Park and receives strategic funding from the Biotechnology and Biological Science Research Council (BBSRC) and other research funders.

TGAC is one of eight institutes that receive strategic funding from BBSRC and received a total of £21.4M investment in 2011-12, including £16M capital funding.

TGAC offers state of the art DNA sequencing facility, unique by its operation of multiple complementary technologies for data generation. The Institute is a UK hub for innovative Bioinformatics through research, analysis and interpretation of multiple, complex data sets. It hosts one of the largest computing hardware facilities dedicated to life science research in Europe. It is also actively involved in developing novel platforms to provide access to computational tools and processing capacity for multiple academic and industrial users, and promoting applications of computational Bioscience. Additionally, the Institute offers a Training programme through courses and workshops, and an Outreach programme targeting schools, teachers and the general public through dialogue and science communication activities, http://www.tgac.ac.uk/training-outreach/.

The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. http://www.sanger.ac.uk

The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests. http://www.wellcome.ac.uk

Contact details Don Powell Media Manager
Wellcome Trust Sanger Institute
Hinxton, Cambridge, CB10 1SA, UK
Tel +44 (0)1223 496 928
Mobile +44 (0)7753 7753 97
Email press.office@sanger.ac.uk

End of Notes to Editors

ELSE PRESS RELEASES FROM THIS DATE:

DREAM and Sage Bionetworks tap the wisdom of the crowd to impact breast cancer prognosis

2013-04-18

ABOUT THE DREAM PROJECT The Dialogue on Reverse Engineering Assessment and Methods Project (DREAM Project), founded in 2006 by Andrea Califano (Columbia University) and Gustavo Stolovitzky (IBM), was originally conceived as an initiative to advance thenascent field of network biology through the organization of Challenges on network reconstruction and pathway inference. Since the first set of network inference challenges of 2007 (DREAM2) the concept of using collaborative-competitions as a vehicle to carry on a meaningful dialogue in the computational biology community ...

Genome sequencing of the living coelacanth sheds light on the evolution of land vertebrate

2013-04-18

An historic fish, with an intriguing past, now has had its genome sequenced, providing a wealth of information on the genetic changes that accompanied the adaptation from an aquatic environment to land. A team of international researchers led by Chris Amemiya, PhD, Director of Molecular Genetics at the Benaroya Research Institute at Virginia Mason (BRI) and Professor of Biology at the University of Washington, will publish "The African coelacanth genome provides insights into tetrapod evolution" April 18 as the cover article in Nature. The coelacanth genome was sequenced ...

Bear baiting may put hunting dogs at risk from wolves

2013-04-18

Bear hunters will tell you that a good way to attract a bear is to put out bait. And in 10 states, including Michigan and Wisconsin, that's perfectly legal. Hunting dogs are another useful technique in the bear-hunter's toolkit, and 17 states say that's just fine. But who else likes bear bait? Gray wolves, that's who. And wolves that are feeling territorial about a bear bait stash can—and sometimes do—kill hunting dogs released at the bait site. Like most interactions between wildlife and human beings, wolf attacks on hunting dogs illustrate a tangled trade-off: ...

Scientists produce best image yet of atoms moving in real time

2013-04-18

VIDEO: Mapping molecular motions -- the "magic " of chemistry revealed. Despite the enormous number of possible arrangements of atoms during a structural transition, such as occurs with changes in charge distribution... Click here for more information. TORONTO, ON – Call it the ultimate nature documentary. Scientists at the University of Toronto have recorded atomic motions in real time, offering a glimpse into the very essence of chemistry and biology at the ...

Discovery may help prevent HIV 'reservoirs' from forming

2013-04-18

April 17, 2013 — (BRONX, NY) — Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated. HIV-1 is the virus that causes AIDS, and the discovery could lead to novel approaches for addressing HIV-1 "in hiding" – namely eliminating reservoirs of HIV-1 that persist in patients undergoing antiretroviral therapy. The study was published today in the online edition of the journal Cell Host & Microbe. Antiretroviral therapy can reduce blood levels of HIV-1 until ...

Blood pressure out of control at safety-net clinics

2013-04-18

Federally funded safety-net clinics for the uninsured lag behind other health care providers in controlling blood pressure among the low-income patients who rely on them for care, a new Michigan State University analysis suggests. High blood pressure, or hypertension, is a major risk factor for cardiovascular complications including heart disease and stroke, and is especially common and dangerous for patients with diabetes, said lead researcher Adesuwa Olomu, associate professor in the MSU Department of Medicine. In recent decades, a growing share of the 67 million ...

IDRI and Medicago report positive results for Phase I clinical trial for an H5N1 vaccine

2013-04-18

SEATTLE, WA, and QUEBEC CITY, QC, April 17, 2013 – IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 ...

Anti-sickling therapies should be focus for sickle cell science

2013-04-18

AUGUSTA, Ga. – Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition. Rather scientists need to get back to the crux of the disease affecting 1 in 500 black Americans and find better ways to prevent the hallmark sickling that impedes red blood cells' oxygen delivery, damaging blood vessel walls and organs along the way, said Dr. Abdullah Kutlar, Director of the Sickle Cell Center at the Medical College of Georgia at Georgia Regents ...

Astronomers discover massive star factory in early universe

2013-04-18

Smaller begets bigger. Such is often the case for galaxies, at least: the first galaxies were small, then eventually merged together to form the behemoths we see in the present universe. Those smaller galaxies produced stars at a modest rate; only later—when the universe was a couple of billion years old—did the vast majority of larger galaxies begin to form and accumulate enough gas and dust to become prolific star factories. Indeed, astronomers have observed that these star factories—called starburst galaxies—became prevalent a couple of billion years after the Big ...

The doctor won't see you now? Study: US facing a neurologist shortage

2013-04-18

MINNEAPOLIS – Americans with brain diseases such as Alzheimer's disease, Parkinson's disease or multiple sclerosis (MS) who need to see a neurologist may face longer wait times or have more difficulty finding a neurologist, according to a new study published in the April 17, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The findings are being released as nearly 150 neurologists will descend on Capitol Hill next Tuesday, April 23, 2013, to encourage Congress to protect patients' access to neurologists and ensure there will be ...

ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D

Increasing the number of coronary interventions in patients with acute myocardial infarction does not appear to reduce death rates

Striking genomic architecture discovered in embryonic reproductive cells before they start developing into sperm and eggs

AABNet and partners launch landmark guide on the conservation of African livestock genetic resources and sustainable breeding strategies

[Press-News.org] Family ties: Relationship between human and zebrafish genomes
Completion of the zebrafish reference genome yields strong comparisons with the human genome

Family ties: Relationship between human and zebrafish genomes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: